ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,371.50
-0.82%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Better Therapeutics Inc (BTTX)

  7. Better Therapeutics Inc (BTTX) Noticias

BTTX

Better Therapeutics (BTTX)

Better Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BTTX
FechaHoraFuenteTítuloSímboloCompañía
14/03/202408:38Business WireBetter Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from NasdaqNASDAQ:BTTXBetter Therapeutics Inc
11/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTTXBetter Therapeutics Inc
05/03/202408:25Business WireBetter Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health CentersNASDAQ:BTTXBetter Therapeutics Inc
04/03/202408:25Business WireBetter Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)NASDAQ:BTTXBetter Therapeutics Inc
01/03/202405:08Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BTTXBetter Therapeutics Inc
20/02/202408:25Business WireBetter Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver DiseaseNASDAQ:BTTXBetter Therapeutics Inc
12/02/202415:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
06/02/202408:43Business WireBetter Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes TreatmentNASDAQ:BTTXBetter Therapeutics Inc
06/02/202408:02Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
23/01/202416:22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BTTXBetter Therapeutics Inc
17/01/202408:28Business WireBetter Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care AloneNASDAQ:BTTXBetter Therapeutics Inc
10/01/202406:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BTTXBetter Therapeutics Inc
04/01/202413:00Business WireBetter Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United StatesNASDAQ:BTTXBetter Therapeutics Inc
02/01/202406:45Business WireBetter Therapeutics Announces Submission for FDA Breakthrough Device Designation for Digital Therapeutic Platform to Treat Liver DiseaseNASDAQ:BTTXBetter Therapeutics Inc
27/12/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BTTXBetter Therapeutics Inc
20/12/202316:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
13/12/202316:24Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BTTXBetter Therapeutics Inc
07/12/202319:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BTTXBetter Therapeutics Inc
28/11/202306:45Business WireBetter Therapeutics Strengthens Financial Position Through Amendment to Debt Facility and Implementation of Cost ReductionsNASDAQ:BTTXBetter Therapeutics Inc
14/11/202306:00Business WireFrost & Sullivan Honors Better Therapeutics with the 2023 Technology Innovation Leadership AwardNASDAQ:BTTXBetter Therapeutics Inc
09/11/202306:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BTTXBetter Therapeutics Inc
09/11/202306:00Business WireBetter Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:BTTXBetter Therapeutics Inc
08/11/202306:30Business WireBetter Therapeutics to Release Third Quarter 2023 Financial Results and Provide Business Update on November 09, 2023NASDAQ:BTTXBetter Therapeutics Inc
26/10/202306:55Business WireBetter Therapeutics to Participate in the American College of Lifestyle Medicine’s 2023 Annual ConferenceNASDAQ:BTTXBetter Therapeutics Inc
16/10/202306:55Business WireBetter Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 DiabetesNASDAQ:BTTXBetter Therapeutics Inc
16/10/202306:22Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BTTXBetter Therapeutics Inc
12/10/202315:17Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BTTXBetter Therapeutics Inc
11/10/202306:55Business WireBetter Therapeutics Announces New Data Highlighting Concurrent Use of AspyreRx and GLP-1 Receptor Agonists to Treat Type 2 DiabetesNASDAQ:BTTXBetter Therapeutics Inc
06/10/202315:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BTTXBetter Therapeutics Inc
05/10/202306:45Business WireBetter Therapeutics Announces Publication of LivVita Liver Disease Study Results in Gastro Hep AdvancesNASDAQ:BTTXBetter Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BTTX

Su Consulta Reciente

PM
XAUUSD
Gold vs US Dollar
AMEX
XLE
Energy Select Sector SPDR
AMEX
SPY
SPDR S&P 500
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
NASDAQ
GOOGL
Alphabet
NYSE
DIS
Walt Disney
NYSE
CVX
Chevron
NYSE
BAC
Bank of America
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
CCOM
OILBRENT
Brent Oil
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
FX
USDMXN
US Dollar vs MXN
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados